OCTRU Trials Hub
@octructu.bsky.social
Oxford Clinical Trials Research Unit (OCTRU) is a UKCRC fully registered Clinical Trials Unit, based within the University of Oxford @ox.ac.uk
🌐 https://www.ndorms.ox.ac.uk/octru
🌐 https://www.ndorms.ox.ac.uk/octru
Pinned
OCTRU Trials Hub
@octructu.bsky.social
· Jul 18
The EXPLAIN Initiative has produced generic multilingual Explainer Animations for three key topics in clinical studies - available to use for free for studies at CTUs across the @ukcrc-ctu.org.uk network.
To find out more, and to request the use of the videos, visit explain.octru.ox.ac.uk
To find out more, and to request the use of the videos, visit explain.octru.ox.ac.uk
It's day number 9️⃣ of our advent calendar! 📆 🎄
Today we introduce GEKO!🦎
@geko-study.bsky.social hopes to find out if a new treatment can help provide relief to people with knee osteoarthritis where simple treatments no longer work, but surgery isn’t yet necessary.
🌐 geko.octru.ox.ac.uk
Today we introduce GEKO!🦎
@geko-study.bsky.social hopes to find out if a new treatment can help provide relief to people with knee osteoarthritis where simple treatments no longer work, but surgery isn’t yet necessary.
🌐 geko.octru.ox.ac.uk
December 9, 2025 at 12:01 PM
It's day number 9️⃣ of our advent calendar! 📆 🎄
Today we introduce GEKO!🦎
@geko-study.bsky.social hopes to find out if a new treatment can help provide relief to people with knee osteoarthritis where simple treatments no longer work, but surgery isn’t yet necessary.
🌐 geko.octru.ox.ac.uk
Today we introduce GEKO!🦎
@geko-study.bsky.social hopes to find out if a new treatment can help provide relief to people with knee osteoarthritis where simple treatments no longer work, but surgery isn’t yet necessary.
🌐 geko.octru.ox.ac.uk
It's day number 8️⃣ of our advent calendar! 📆 🎄
Today we introduce WHiTE INITIATE!
The study aims to find out if more ward-based mobilisation activity after hip fracture surgery allows people to get home more quickly and allow them to stay living in their own home longer.
initiate.octru.ox.ac.uk
Today we introduce WHiTE INITIATE!
The study aims to find out if more ward-based mobilisation activity after hip fracture surgery allows people to get home more quickly and allow them to stay living in their own home longer.
initiate.octru.ox.ac.uk
December 8, 2025 at 12:05 PM
It's day number 8️⃣ of our advent calendar! 📆 🎄
Today we introduce WHiTE INITIATE!
The study aims to find out if more ward-based mobilisation activity after hip fracture surgery allows people to get home more quickly and allow them to stay living in their own home longer.
initiate.octru.ox.ac.uk
Today we introduce WHiTE INITIATE!
The study aims to find out if more ward-based mobilisation activity after hip fracture surgery allows people to get home more quickly and allow them to stay living in their own home longer.
initiate.octru.ox.ac.uk
It's day number 7️⃣ of our advent calendar! 📆 🎄
Today we introduce EndoNET!
The EndoNET study compares two treatment pathways for oestrogen receptor positive breast cancer in post-menopausal women who require surgery.
Find out more: www.nds.ox.ac.uk/research/sur...
Today we introduce EndoNET!
The EndoNET study compares two treatment pathways for oestrogen receptor positive breast cancer in post-menopausal women who require surgery.
Find out more: www.nds.ox.ac.uk/research/sur...
December 7, 2025 at 12:01 PM
It's day number 7️⃣ of our advent calendar! 📆 🎄
Today we introduce EndoNET!
The EndoNET study compares two treatment pathways for oestrogen receptor positive breast cancer in post-menopausal women who require surgery.
Find out more: www.nds.ox.ac.uk/research/sur...
Today we introduce EndoNET!
The EndoNET study compares two treatment pathways for oestrogen receptor positive breast cancer in post-menopausal women who require surgery.
Find out more: www.nds.ox.ac.uk/research/sur...
It's day number 6️⃣ of our advent calendar! 📆 🎄
Today we introduce LEADER!
Rheumatoid arthritis (RA) causes joint pain and swelling-the LEADER study is trying to find out the best way of using steroids which are routinely used to treat the symptoms of RA. 💊 💉
Find out more: leader.octru.ox.ac.uk
Today we introduce LEADER!
Rheumatoid arthritis (RA) causes joint pain and swelling-the LEADER study is trying to find out the best way of using steroids which are routinely used to treat the symptoms of RA. 💊 💉
Find out more: leader.octru.ox.ac.uk
December 6, 2025 at 12:01 PM
It's day number 6️⃣ of our advent calendar! 📆 🎄
Today we introduce LEADER!
Rheumatoid arthritis (RA) causes joint pain and swelling-the LEADER study is trying to find out the best way of using steroids which are routinely used to treat the symptoms of RA. 💊 💉
Find out more: leader.octru.ox.ac.uk
Today we introduce LEADER!
Rheumatoid arthritis (RA) causes joint pain and swelling-the LEADER study is trying to find out the best way of using steroids which are routinely used to treat the symptoms of RA. 💊 💉
Find out more: leader.octru.ox.ac.uk
It's day number 5️⃣ of our advent calendar! 📆 🎄
Today we introduce MILI
MILI is a clinical trial investigating the use of a drug called metformin as a way of reducing the cancer risk in people with Li Fraumeni Syndrome (LFS)
Find out more: mili.octru.ox.ac.uk
@octooxford.bsky.social
Today we introduce MILI
MILI is a clinical trial investigating the use of a drug called metformin as a way of reducing the cancer risk in people with Li Fraumeni Syndrome (LFS)
Find out more: mili.octru.ox.ac.uk
@octooxford.bsky.social
December 5, 2025 at 12:03 PM
It's day number 5️⃣ of our advent calendar! 📆 🎄
Today we introduce MILI
MILI is a clinical trial investigating the use of a drug called metformin as a way of reducing the cancer risk in people with Li Fraumeni Syndrome (LFS)
Find out more: mili.octru.ox.ac.uk
@octooxford.bsky.social
Today we introduce MILI
MILI is a clinical trial investigating the use of a drug called metformin as a way of reducing the cancer risk in people with Li Fraumeni Syndrome (LFS)
Find out more: mili.octru.ox.ac.uk
@octooxford.bsky.social
It's day number 4️⃣ of our advent calendar! 📆 🎄
Today we introduce ACL-STARR ⭐
The ACL STARR study is investigating which is the best surgical option for people who have torn their Anterior Cruciate Ligament (ACL) 🧎
Find out more about the study here:
aclstarr.com
@situ-oxford.bsky.social
Today we introduce ACL-STARR ⭐
The ACL STARR study is investigating which is the best surgical option for people who have torn their Anterior Cruciate Ligament (ACL) 🧎
Find out more about the study here:
aclstarr.com
@situ-oxford.bsky.social
December 4, 2025 at 12:02 PM
It's day number 4️⃣ of our advent calendar! 📆 🎄
Today we introduce ACL-STARR ⭐
The ACL STARR study is investigating which is the best surgical option for people who have torn their Anterior Cruciate Ligament (ACL) 🧎
Find out more about the study here:
aclstarr.com
@situ-oxford.bsky.social
Today we introduce ACL-STARR ⭐
The ACL STARR study is investigating which is the best surgical option for people who have torn their Anterior Cruciate Ligament (ACL) 🧎
Find out more about the study here:
aclstarr.com
@situ-oxford.bsky.social
It's day number 3️⃣ of our advent calendar! 📆 🎄
Today we look at our portfolio of open studies - thank you to all who are managing and working on our studies across all groups for their hard work in 2025 & for all our participants who are taking part! 🏥 🩺💊
Today we look at our portfolio of open studies - thank you to all who are managing and working on our studies across all groups for their hard work in 2025 & for all our participants who are taking part! 🏥 🩺💊
December 3, 2025 at 12:02 PM
It's day number 3️⃣ of our advent calendar! 📆 🎄
Today we look at our portfolio of open studies - thank you to all who are managing and working on our studies across all groups for their hard work in 2025 & for all our participants who are taking part! 🏥 🩺💊
Today we look at our portfolio of open studies - thank you to all who are managing and working on our studies across all groups for their hard work in 2025 & for all our participants who are taking part! 🏥 🩺💊
It's day number 2️⃣ of our advent calendar! 📆 🎄
OCTRU is a single UKCRC registered CTU comprised of mulitple trials groups working in different therapeutic areas: @octooxford.bsky.social, @situ-oxford.bsky.social (NDORMS & NDS), @oxtraumaresearch.bsky.social and Experimental Medicine and Rheumatology
OCTRU is a single UKCRC registered CTU comprised of mulitple trials groups working in different therapeutic areas: @octooxford.bsky.social, @situ-oxford.bsky.social (NDORMS & NDS), @oxtraumaresearch.bsky.social and Experimental Medicine and Rheumatology
December 2, 2025 at 12:04 PM
It's day number 2️⃣ of our advent calendar! 📆 🎄
OCTRU is a single UKCRC registered CTU comprised of mulitple trials groups working in different therapeutic areas: @octooxford.bsky.social, @situ-oxford.bsky.social (NDORMS & NDS), @oxtraumaresearch.bsky.social and Experimental Medicine and Rheumatology
OCTRU is a single UKCRC registered CTU comprised of mulitple trials groups working in different therapeutic areas: @octooxford.bsky.social, @situ-oxford.bsky.social (NDORMS & NDS), @oxtraumaresearch.bsky.social and Experimental Medicine and Rheumatology
Happy December and welcome to the OCTRU Advent Calendar 2025! 📆🎄
We hope that you can learn more about us and our studies throughout this festive period! 🌟☃️❄️
We hope that you can learn more about us and our studies throughout this festive period! 🌟☃️❄️
December 1, 2025 at 12:12 PM
Happy December and welcome to the OCTRU Advent Calendar 2025! 📆🎄
We hope that you can learn more about us and our studies throughout this festive period! 🌟☃️❄️
We hope that you can learn more about us and our studies throughout this festive period! 🌟☃️❄️
As we say hello to December, we celebrate @geko-study.bsky.social who achieved their best month of recruitment to date in November!
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
@situ-oxford.bsky.social
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
@situ-oxford.bsky.social
December 1, 2025 at 11:56 AM
As we say hello to December, we celebrate @geko-study.bsky.social who achieved their best month of recruitment to date in November!
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
@situ-oxford.bsky.social
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
@situ-oxford.bsky.social
Reposted by OCTRU Trials Hub
🚨New guidance for CTUs
Making optimal use of clinical trial data is an ethical obligation & often a funder requirement.
Our guidance, written by experienced trial staff, can help you prepare for data sharing & re-use requests.
🔗 ukcrc-ctu.org.uk/quality-assu...
#ClinicalTrials #UKCTUNetwork
Making optimal use of clinical trial data is an ethical obligation & often a funder requirement.
Our guidance, written by experienced trial staff, can help you prepare for data sharing & re-use requests.
🔗 ukcrc-ctu.org.uk/quality-assu...
#ClinicalTrials #UKCTUNetwork
November 24, 2025 at 10:25 AM
🚨New guidance for CTUs
Making optimal use of clinical trial data is an ethical obligation & often a funder requirement.
Our guidance, written by experienced trial staff, can help you prepare for data sharing & re-use requests.
🔗 ukcrc-ctu.org.uk/quality-assu...
#ClinicalTrials #UKCTUNetwork
Making optimal use of clinical trial data is an ethical obligation & often a funder requirement.
Our guidance, written by experienced trial staff, can help you prepare for data sharing & re-use requests.
🔗 ukcrc-ctu.org.uk/quality-assu...
#ClinicalTrials #UKCTUNetwork
Reposted by OCTRU Trials Hub
Introducing our Meet The MILI Team series!
Each week will feature a different team member.
We are starting off with the brains behind the trial, our very own Clinical Investigator, Prof Sarah Blagden:
#LFS #LiFraumeni @oncology.ox.ac.uk @oxfordcancer.bsky.social
tp53.co.uk/lfs-tp53/
Each week will feature a different team member.
We are starting off with the brains behind the trial, our very own Clinical Investigator, Prof Sarah Blagden:
#LFS #LiFraumeni @oncology.ox.ac.uk @oxfordcancer.bsky.social
tp53.co.uk/lfs-tp53/
November 10, 2025 at 10:26 AM
Introducing our Meet The MILI Team series!
Each week will feature a different team member.
We are starting off with the brains behind the trial, our very own Clinical Investigator, Prof Sarah Blagden:
#LFS #LiFraumeni @oncology.ox.ac.uk @oxfordcancer.bsky.social
tp53.co.uk/lfs-tp53/
Each week will feature a different team member.
We are starting off with the brains behind the trial, our very own Clinical Investigator, Prof Sarah Blagden:
#LFS #LiFraumeni @oncology.ox.ac.uk @oxfordcancer.bsky.social
tp53.co.uk/lfs-tp53/
Hello November! We start the month by congratulating the @forensic-uk.bsky.social , GEKO, MILI, ODDSOCKS & REACH studies who achieved their best month of recruitment to date in October! 👏
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
November 3, 2025 at 1:03 PM
Hello November! We start the month by congratulating the @forensic-uk.bsky.social , GEKO, MILI, ODDSOCKS & REACH studies who achieved their best month of recruitment to date in October! 👏
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
Thank you to everyone taking part in all of our studies, and to all of our study teams & sites.
As we say hello to October, we celebrate the studies that achieved their best month of recruitment of all time in September!
LEADER
FORENSIC
Thank you to everyone taking part in our research & to our teams for their work across all of our studies!
LEADER
FORENSIC
Thank you to everyone taking part in our research & to our teams for their work across all of our studies!
October 1, 2025 at 1:53 PM
As we say hello to October, we celebrate the studies that achieved their best month of recruitment of all time in September!
LEADER
FORENSIC
Thank you to everyone taking part in our research & to our teams for their work across all of our studies!
LEADER
FORENSIC
Thank you to everyone taking part in our research & to our teams for their work across all of our studies!
Reposted by OCTRU Trials Hub
17 September is #WorldPatientSafetyDay2025.
But patient safety is a year-round commitment inc. in clinical trials.
The EXPLAIN Project developed animations to illustrate to patients & participants how safety in trials is overseen.
Find out more here ukcrc-ctu.org.uk/explain-wpsd...
#UKCTUNetwork
But patient safety is a year-round commitment inc. in clinical trials.
The EXPLAIN Project developed animations to illustrate to patients & participants how safety in trials is overseen.
Find out more here ukcrc-ctu.org.uk/explain-wpsd...
#UKCTUNetwork
September 15, 2025 at 1:55 PM
17 September is #WorldPatientSafetyDay2025.
But patient safety is a year-round commitment inc. in clinical trials.
The EXPLAIN Project developed animations to illustrate to patients & participants how safety in trials is overseen.
Find out more here ukcrc-ctu.org.uk/explain-wpsd...
#UKCTUNetwork
But patient safety is a year-round commitment inc. in clinical trials.
The EXPLAIN Project developed animations to illustrate to patients & participants how safety in trials is overseen.
Find out more here ukcrc-ctu.org.uk/explain-wpsd...
#UKCTUNetwork
We can't believe it's already September!
Well done to the LEADER study who achieved their best month of recruitment to date in August! 👏
Find out more about the study here: leader.octru.ox.ac.uk
& thank you to everyone taking part in all of our studies, and to all of our hardworking teams!
Well done to the LEADER study who achieved their best month of recruitment to date in August! 👏
Find out more about the study here: leader.octru.ox.ac.uk
& thank you to everyone taking part in all of our studies, and to all of our hardworking teams!
September 2, 2025 at 2:57 PM
We can't believe it's already September!
Well done to the LEADER study who achieved their best month of recruitment to date in August! 👏
Find out more about the study here: leader.octru.ox.ac.uk
& thank you to everyone taking part in all of our studies, and to all of our hardworking teams!
Well done to the LEADER study who achieved their best month of recruitment to date in August! 👏
Find out more about the study here: leader.octru.ox.ac.uk
& thank you to everyone taking part in all of our studies, and to all of our hardworking teams!
The MACRO study's results paper has been published in @thelancet.com - well done to all involved, and thank you to all participants!! 👏
Find out more ⤵️
www.ndorms.ox.ac.uk/news/surgery...
Read the paper ⤵️
www.thelancet.com/journals/lan...
#CRS #ClinicalTrials #OpenAccess
Find out more ⤵️
www.ndorms.ox.ac.uk/news/surgery...
Read the paper ⤵️
www.thelancet.com/journals/lan...
#CRS #ClinicalTrials #OpenAccess
Surgery to treat chronic sinus disease more effective than antibiotics
Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by UCL, coordinated by the Oxford Clinical Trials Research Unit (OCTRU) and...
www.ndorms.ox.ac.uk
August 29, 2025 at 1:06 PM
The MACRO study's results paper has been published in @thelancet.com - well done to all involved, and thank you to all participants!! 👏
Find out more ⤵️
www.ndorms.ox.ac.uk/news/surgery...
Read the paper ⤵️
www.thelancet.com/journals/lan...
#CRS #ClinicalTrials #OpenAccess
Find out more ⤵️
www.ndorms.ox.ac.uk/news/surgery...
Read the paper ⤵️
www.thelancet.com/journals/lan...
#CRS #ClinicalTrials #OpenAccess
Reposted by OCTRU Trials Hub
SARONG has reached 700 participants! We're incredibly grateful to all the research teams and participants who made this milestone possible. @sherazmarkar.bsky.social @octructu.bsky.social @ndsurgicalsci.bsky.social @situ-oxford.bsky.social
August 6, 2025 at 9:08 AM
SARONG has reached 700 participants! We're incredibly grateful to all the research teams and participants who made this milestone possible. @sherazmarkar.bsky.social @octructu.bsky.social @ndsurgicalsci.bsky.social @situ-oxford.bsky.social
Reposted by OCTRU Trials Hub
The #UKCTUNetwork is committed to fostering a supportive, collaborative & transparent environment across CTUs—driven by continuous improvement, knowledge-sharing, and mutual respect for experience and insight.
Learn more: ukcrc-ctu.org.uk/network-stra... #ClinicalTrials #UKCTUNetworkStrategy
Learn more: ukcrc-ctu.org.uk/network-stra... #ClinicalTrials #UKCTUNetworkStrategy
August 5, 2025 at 9:25 AM
The #UKCTUNetwork is committed to fostering a supportive, collaborative & transparent environment across CTUs—driven by continuous improvement, knowledge-sharing, and mutual respect for experience and insight.
Learn more: ukcrc-ctu.org.uk/network-stra... #ClinicalTrials #UKCTUNetworkStrategy
Learn more: ukcrc-ctu.org.uk/network-stra... #ClinicalTrials #UKCTUNetworkStrategy
As we welcome August we celebrate the studies that acheieved their best month of recruitment to date in July!
Well done to the @sarongtrial.bsky.social, TaILOR, and INITIATE teams, and thank you to everyone taking part in, and working on, all of our studies! 👏
Well done to the @sarongtrial.bsky.social, TaILOR, and INITIATE teams, and thank you to everyone taking part in, and working on, all of our studies! 👏
August 1, 2025 at 11:00 AM
As we welcome August we celebrate the studies that acheieved their best month of recruitment to date in July!
Well done to the @sarongtrial.bsky.social, TaILOR, and INITIATE teams, and thank you to everyone taking part in, and working on, all of our studies! 👏
Well done to the @sarongtrial.bsky.social, TaILOR, and INITIATE teams, and thank you to everyone taking part in, and working on, all of our studies! 👏
Reposted by OCTRU Trials Hub
Huge milestone for the SARONG team! July 2025 has been the best recruiting month yet — 5️⃣4️⃣ new participants joined, bringing us to 6️⃣8️⃣7️⃣ randomised in total! We're incredibly grateful to our amazing sites, participants, and the NIHR for their continued support.
@sherazmarkar.bsky.social
@sherazmarkar.bsky.social
July 31, 2025 at 4:12 PM
Huge milestone for the SARONG team! July 2025 has been the best recruiting month yet — 5️⃣4️⃣ new participants joined, bringing us to 6️⃣8️⃣7️⃣ randomised in total! We're incredibly grateful to our amazing sites, participants, and the NIHR for their continued support.
@sherazmarkar.bsky.social
@sherazmarkar.bsky.social
Reposted by OCTRU Trials Hub
The MILI site team based at Aberdeen Royal Infirmary share what this study means to them.
Find out more about MILI here: mili.octru.ox.ac.uk
#LFS #TP53 #LiFraumeniSyndrome @NHSGrampian
Find out more about MILI here: mili.octru.ox.ac.uk
#LFS #TP53 #LiFraumeniSyndrome @NHSGrampian
July 24, 2025 at 11:17 AM
The MILI site team based at Aberdeen Royal Infirmary share what this study means to them.
Find out more about MILI here: mili.octru.ox.ac.uk
#LFS #TP53 #LiFraumeniSyndrome @NHSGrampian
Find out more about MILI here: mili.octru.ox.ac.uk
#LFS #TP53 #LiFraumeniSyndrome @NHSGrampian
Reposted by OCTRU Trials Hub
Interested in or currently leading a clinical trial?
Want to be the best Chief Investigator you can be?
Want to build a peer support network?
This UPDATED course is for you!
⏰Registration for the October 2025 workshop in Glasgow is now open.⏰
Find out more here: ukcrc-ctu.org.uk/how-to-be-a-...
Want to be the best Chief Investigator you can be?
Want to build a peer support network?
This UPDATED course is for you!
⏰Registration for the October 2025 workshop in Glasgow is now open.⏰
Find out more here: ukcrc-ctu.org.uk/how-to-be-a-...
July 24, 2025 at 1:23 PM
Interested in or currently leading a clinical trial?
Want to be the best Chief Investigator you can be?
Want to build a peer support network?
This UPDATED course is for you!
⏰Registration for the October 2025 workshop in Glasgow is now open.⏰
Find out more here: ukcrc-ctu.org.uk/how-to-be-a-...
Want to be the best Chief Investigator you can be?
Want to build a peer support network?
This UPDATED course is for you!
⏰Registration for the October 2025 workshop in Glasgow is now open.⏰
Find out more here: ukcrc-ctu.org.uk/how-to-be-a-...
The EXPLAIN Initiative has produced generic multilingual Explainer Animations for three key topics in clinical studies - available to use for free for studies at CTUs across the @ukcrc-ctu.org.uk network.
To find out more, and to request the use of the videos, visit explain.octru.ox.ac.uk
To find out more, and to request the use of the videos, visit explain.octru.ox.ac.uk
July 18, 2025 at 11:01 AM
The EXPLAIN Initiative has produced generic multilingual Explainer Animations for three key topics in clinical studies - available to use for free for studies at CTUs across the @ukcrc-ctu.org.uk network.
To find out more, and to request the use of the videos, visit explain.octru.ox.ac.uk
To find out more, and to request the use of the videos, visit explain.octru.ox.ac.uk
We had a brilliant Summer Meeting yesterday! 🌞
Great to hear from all our groups on their achievements and innovations, and from our guest speaker Adwoa Parker for an engaging and informative talk!
Congratulations also to the nominees and winners of our CTU awards for 2024!
Great to hear from all our groups on their achievements and innovations, and from our guest speaker Adwoa Parker for an engaging and informative talk!
Congratulations also to the nominees and winners of our CTU awards for 2024!
July 11, 2025 at 9:01 AM
We had a brilliant Summer Meeting yesterday! 🌞
Great to hear from all our groups on their achievements and innovations, and from our guest speaker Adwoa Parker for an engaging and informative talk!
Congratulations also to the nominees and winners of our CTU awards for 2024!
Great to hear from all our groups on their achievements and innovations, and from our guest speaker Adwoa Parker for an engaging and informative talk!
Congratulations also to the nominees and winners of our CTU awards for 2024!